Trials / NCT02309866
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases
Status unknown Observational Natural history / observational
- Sponsor
- Hillel Yaffe Medical Center
- Treatment
- Genetic testing
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- Any to no upper limit
- Enrollment
- 100 participants
- Started
- 2015-01
- Main results expected
- 2017-01
- Results posted
- Not yet
- Record last updated
- 2014-12-05
What the study is testing
Retinitis Pigmentosa (RP) is the most common form of hereditary retinal degeneration, with a worldwide prevalence of 1:3500. It is one of the most genetically heterogenous conditions in humans, with over 100 causative genes and loci reported to date. However, in approximately 40% of patients the underlying genetic causes are yet to be found.
The current study aims to identify causative RP genes and mutations in Israeli families of various ethnic backgrounds. Identification of such genes will contribute significantly to disease prevention (by identification of high risk families and appropriate genetic counseling) and to the investigators understanding of retinal structure and function and of the etiology of RP.
Where it runs
No sites listed yet.